| Members |
targetComponentId |
| Disodium tiludronate (product) |
acide tiludronique |
| Disopyramide phosphate 100mg capsule (product) |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 100mg m/r capsule (product) |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg m/r tablet (product) |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 100mg prolonged-release oral tablet |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 150mg (product) |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 150mg capsule (product) |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 150mg m/r capsule (product) |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 150mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
| Disorder involving the integument of fetus or newborn, NEC (disorder) |
Disorder involving the integument of fetus OR newborn |
| Disorder of amino acid transport (disorder) |
Amino acid transport disorder |
| Disorder of balance |
Impairment of balance (finding) |
| Disorder of heart caused by Salmonella enterica subspecies enterica serovar Typhi (disorder) |
Infection of heart caused by Salmonella enterica subspecies enterica serovar Typhi (disorder) |
| Disorder of hemostasis (disorder) |
Blood coagulation disorder |
| Disorder of iris AND/OR ciliary body (disorder) |
Disorder of uveal tract |
| Disorder of pregnancy |
problème de grossesse |
| Disorder of skeletal muscle |
affection d'un muscle squelettique |
| Disorder of transport, NEC (disorder) |
trouble métabolique du transport |
| Dispensing of unlisted low vision aid (procedure) |
appareillage et distribution de lunettes |
| Displaced tooth (morphologic abnormality) |
Displaced tooth |
| Displacement - action |
Action |
| Displacement, first degree |
Displacement |
| Displacement, second degree |
Displacement |
| Displacement, third degree |
Displacement |
| Disproportion of other origin, NEC |
Disproportion between fetus and pelvis |
| Disrupted episiotomy wound |
Disruption of episiotomy wound in the puerperium (disorder) |
| Disrupted laceration wound site (morphologic abnormality) |
Disrupted wound |
| Dissecting aneurysm of coronary artery |
Dissection of coronary artery (disorder) |
| Disseminated chorioretinitis and retinochoroiditis NOS (disorder) |
Disseminated chorioretinitis |
| Disseminated paracoccidioidomycosis (disorder) |
Disseminated paracoccidioidomycosis (disorder) |
| Dist fasciocutaneous flap NOS |
Distant fasciocutaneous flap |
| Distal interphalangeal joint structure of great toe (body structure) |
Interphalangeal joint structure of great toe |
| Distal monosomy 20q |
20q13.33 microdeletion syndrome (disorder) |
| Distal myopathy with early respiratory muscle involvement (disorder) |
Hereditary myopathy with early respiratory failure |
| Distant cutaneous pedicle skin flap NOS |
Reconstruction using distant pedicle skin flap |
| Distant fasciocutaneous flap to head or neck NEC |
Distant fasciocutaneous flap |
| Distant free flap reconstruction - action (qualifier value) |
Distant flap reconstruction - action (qualifier value) |
| Distant myocutaneous flap NOS |
Distant myocutaneous flap |
| Distant myocutaneous flap to head or neck NEC |
Distant myocutaneous flap |
| Distant pedicle flap reconstruction - action (qualifier value) |
Distant flap reconstruction - action (qualifier value) |
| Distant skin flap to head or neck NEC |
Reconstruction with distant flap |
| Distant subcutaneous pedicle flap, axial pattern NEC |
Reconstruction using distant subcutaneous pedicle axial pattern flap (procedure) |
| Distant subcutaneous pedicle flap, fasciocutaneous NEC |
Distant fasciocutaneous flap |
| Distant subcutaneous pedicle flap, myocutaneous NEC |
Distant myocutaneous flap |
| Distant subcutaneous pedicle flap, random pattern NEC |
Reconstruction using distant subcutaneous pedicle random pattern flap (procedure) |
| Disto-occlusion |
Disto-occlusion of teeth (disorder) |
| Disturbance in form of thinking (disorder) |
Disorder of form of thought |
| Dithranol cream allergy |
Allergy to dithranol (finding) |
| Dithranol ointment allergy |
Allergy to dithranol (finding) |
| Dithranol paste allergy |
Allergy to dithranol (finding) |
| Divalproex sodium 125mg tablet delayed release (product) |
Valproic acid (as divalproex sodium) 125 mg gastro-resistant oral tablet |
| Divalproex sodium 250mg tablet delayed release (product) |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Divalproex sodium 500mg m/r tablet (product) |
Valproic acid only product in oral dose form |
| Divalproex sodium 500mg prolonged-release oral tablet |
Valproic acid only product in oral dose form |
| Diversional therapy |
Diversional therapy (regime/therapy) |
| embranchement : Tenericutes |
Phylum Tenericutes |
| Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial (product) |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Does not, dependent (qualifier value) |
Does not |
| Dog allergy vaccine (substance) |
Dog allergy vaccine (product) |
| Doll's eye sign |
Doll's head reflex |
| Dolphin distemper virus |
Cetacean morbillivirus (organism) |
| Domain Archaea (organism) |
domaine : Archée |
| Domestic animal species, non-primate |
Class Mammalia (organism) |
| Domestic animals |
Class Mammalia (organism) |
| Donepezil 10mg orally disintegrating tablet (product) |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Donepezil 1mg/mL oral solution (product) |
Donepezil hydrochloride 1 mg/mL oral solution |
| Donepezil 5mg orally disintegrating tablet (product) |
Donepezil hydrochloride 5 mg orodispersible tablet |
| Dornase alfa 2500units(2.5mg) nebulizer solution (product) |
Dornase alfa 1 mg/mL solution for inhalation |
| Dorsal finger flap |
Flap (substance) |
| Dorsal metatarsal fasciocutaneous flap |
Dorsal metatarsal artery fasciocutaneous flap |
| Dorsal thumb flap |
Flap (substance) |
| Dorsal tongue flap |
Flap (substance) |
| Dorsalis pedis flap |
Dorsalis pedis artery flap |
| Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
| Dothiepin hydrochloride 25mg/5mL conventional release oral elixir |
Dothiepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 25mg/5mL s/f elixir (product) |
Dothiepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL conventional release oral elixir |
Dothiepin 15 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL s/f elixir (product) |
Dothiepin 15 mg/mL oral solution |
| Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
| Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
| Double pedicle flap graft |
Reconstruction using bipedicled flap |
| Down's incontinence apparatus |
Incontinence appliance |
| Doxazosin mesylate 8mg tablet (product) |
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each conventional release oral tablet (clinical drug) |
| Doxepin hydrochloride 10mg/mL oral solution (product) |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Doxepin metabolite |
Product containing doxepin (medicinal product) |
| Doxorubicin hydrochloride 10mg injection solution vial (product) |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
| Doxorubicin hydrochloride 20mg injection solution vial (product) |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxorubicin liposomal 20mg/10ml injection (product) |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxycycline 100mg dispersible tablet (product) |
Doxycycline 100 mg orodispersible tablet |
| Doxycycline 40mg m/r capsule (product) |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Doxycycline 75mg orally disintegrating tablet (product) |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
| Doxycycline calcium 50mg/5mL syrup (product) |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Doxycycline hyclate 10% subgingival delivery system (product) |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
| Doxycycline hyclate 200mg injection (product) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline hyclate 200mg powder for injection solution vial (product) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline monohydrate 25mg/5mL suspension (product) |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
| Drain insertion - action |
action : insertion |
| Drechslera longirostrata |
Exserohilum longirostratum |
| Dressing - action |
Application - action |
| Dried factor IX fraction heated 600iu powder and solvent for injection solution vial (product) |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
FHIR